Onconic Therapeutics Inc. (KOSDAQ:476060)
20,550
+1,570 (8.27%)
May 21, 2026, 1:40 PM KST
285.01% (1Y)
| Market Cap | 851.97B +198.8% |
| Revenue (ttm) | 53.39B +259.8% |
| Net Income | 15.78B |
| EPS | 347.92 |
| Shares Out | 44.89M |
| PE Ratio | 54.55 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 267,948 |
| Average Volume | 540,221 |
| Open | 19,270 |
| Previous Close | 18,980 |
| Day's Range | 19,270 - 20,700 |
| 52-Week Range | 5,000 - 28,900 |
| Beta | n/a |
| RSI | 39.55 |
| Earnings Date | Mar 20, 2026 |